Effectiveness of a Single 3mg Rasburicase Dose for the Management of Hyperuricemia in Patients with Hematological Malignancies
{"Image DocumentName": "Effectiveness of a Single 3mg Rasburicase Dose for the Management of Hyperuricemia in Patients with Hematological Malignancies", "Image ImageDescription": "3mg rasburicase x 1 dose. Baseline median uric acid: 9.3 mg/dL. Decreased to 5.3 mg/dL \u2013 45%decrease. 51 episodes needed redosed. 42 episodes required 1 additional dose. 5 episodes required 2 additional doses. 4 episodes required 3 additional doses. Baseline serum creatinine : 1.7 mg/dL. 28% of patients had renal failure (2.5 mg/dL) at baseline. Decreased to 1.6 mg/dL at 24 hours. Trifilio SM, et al. Bone Marrow Transplant. 2011;46:800-5.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}